Podcast Episodes

Back to Search
Pharmaceutical Executive Daily: Neurocrine Biosciences Agrees to Acquire Soleno Therapeutics
Pharmaceutical Executive Daily: Neurocrine Biosciences Agrees to Acquire Soleno Therapeutics

In today's Pharmaceutical Executive Daily, Neurocrine Biosciences agrees to acquire Soleno Therapeutics for $2.9 billion to gain Vykat XR, the first …

3 months, 1 week ago

Short Long
View Episode
Pharmaceutical Executive Daily: President Trump Imposes 100% Tariff for Branded Pharmaceuticals
Pharmaceutical Executive Daily: President Trump Imposes 100% Tariff for Branded Pharmaceuticals

In today's Pharmaceutical Executive Daily, President Trump signs an executive order imposing 100% tariffs on imported patented pharmaceuticals under …

3 months, 1 week ago

Short Long
View Episode
Pharmaceutical Executive Daily: Leadership Turnover Under Trump Administration
Pharmaceutical Executive Daily: Leadership Turnover Under Trump Administration

In today’s Pharmaceutical Executive Daily, leadership turnover continues across key federal health agencies under the Trump administration, Shionogi …

3 months, 1 week ago

Short Long
View Episode
Pharmaceutical Executive Daily: Trump Administration Delays Appeal of Federal Ruling Blocking Vaccine Policy Overhaul
Pharmaceutical Executive Daily: Trump Administration Delays Appeal of Federal Ruling Blocking Vaccine Policy Overhaul

In today's Pharmaceutical Executive Daily, the Trump administration delays its appeal of the federal ruling blocking RFK Jr.'s vaccine policy overhau…

3 months, 1 week ago

Short Long
View Episode
Pharmaceutical Executive Daily: Novo Nordisk's Wegovy Subscription Program
Pharmaceutical Executive Daily: Novo Nordisk's Wegovy Subscription Program

In today's Pharmaceutical Executive Daily, Novo Nordisk launches the first multi-month subscription program for Wegovy targeting cash-paying patients…

3 months, 1 week ago

Short Long
View Episode
Pharmaceutical Executive Daily: Eli Lilly Presses U.K. Government to Raise NHS Drug Pricing
Pharmaceutical Executive Daily: Eli Lilly Presses U.K. Government to Raise NHS Drug Pricing

In today's Pharmaceutical Executive Daily, Eli Lilly presses the U.K. government to overhaul its NHS drug pricing framework as a condition of resumin…

3 months, 1 week ago

Short Long
View Episode
Pharmaceutical Executive Daily: Novartis Acquires Excellergy Inc.
Pharmaceutical Executive Daily: Novartis Acquires Excellergy Inc.

In today's Pharmaceutical Executive Daily, Novartis agrees to acquire Excellergy for up to $2 billion to advance a next-generation anti-IgE therapy w…

3 months, 2 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: Trump Administration Misses Deadline to Nominate Permanent CDC Director
Pharmaceutical Executive Daily: Trump Administration Misses Deadline to Nominate Permanent CDC Director

In today's Pharmaceutical Executive Daily, the Trump administration misses a statutory deadline to nominate a permanent CDC director, leaving the age…

3 months, 2 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: FDA Issues Warning Letter to ImmunityBio
Pharmaceutical Executive Daily: FDA Issues Warning Letter to ImmunityBio

In today's Pharmaceutical Executive Daily, the FDA issues a warning letter to ImmunityBio over misleading promotional claims about its bladder cancer…

3 months, 2 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: Bayer Shares Drop After Inclusive Capital Offloads Remaining Stake
Pharmaceutical Executive Daily: Bayer Shares Drop After Inclusive Capital Offloads Remaining Stake

In today's Pharmaceutical Executive Daily, Bayer shares briefly dip after activist investor Inclusive Capital offloads its remaining stake at a loss,…

3 months, 2 weeks ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us